📰 Aematologic News
Page 2 - Aematologic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aematologic. Real-time updates on events, politics, business and more.
March 27, 2023
IMV Inc. , a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today announced changes to its board... | March 27, 2023
November 10, 2022
LONDON, Nov. 10, 2022 /PRNewswire/ -- According to the latest market research, The Global Hematologic Malignancies Treatment Market is valued at US$ 51.97 Billion in 2021, and it is expected
November 3, 2022
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022
September 1, 2022
IMV Inc. , a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that members of... | September 1, 2022
August 3, 2022
Geron Corporation , a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D.,... | August 3, 2022
January 25, 2022
COPENHAGEN, Denmark, Jan. 25, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, has been granted Fast Track designation by the U.S. Food and Drug Administration
November 1, 2021
Hematologic Malignancies Testing Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027
October 27, 2021
Hematologic Malignancies Market To Reach USD 120.56 Billion By 2028 With CAGR of 10.7% - Reports And Data
May 26, 2021
Further analysis from the Phase 3 ANDROMEDA study presented at the 2021 ASCO Annual Meeting also show doubling rates of organ response with no new safety signals The Janssen Pharmaceutical Companies